Platform Therapeutics, Inc., a biotech startup dedicated to developing medicine for critically ill patients, has secured $1.8M in seed funding. The capital infusion marks a significant early milestone for the company, signaling investor confidence in its mission to tackle some of the most urgent medical challenges.
This initial seed round provides a crucial financial foundation for Platform Therapeutics, Inc. as it works to advance new therapeutic options. The funding will support the firm's efforts to bring innovative treatments to those in urgent need, addressing critical unmet medical needs within the patient community.

















